The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.
Zanelli, G., Rossetti, B., Gagliardini, R., Paglicci, L., Tordini, G., Miracco, C., et al. (2019). Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management. LE INFEZIONI IN MEDICINA, 27(4), 452-455.
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management
Giacomo Zanelli
Supervision
;Barbara RossettiWriting – Review & Editing
;Roberta GagliardiniWriting – Review & Editing
;Lorenzo PaglicciWriting – Original Draft Preparation
;Giacinta TordiniWriting – Review & Editing
;Clelia MiraccoWriting – Review & Editing
;Sara AversaWriting – Review & Editing
;Francesca MontagnaniWriting – Review & Editing
2019-01-01
Abstract
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Vol_27_4_2019_16.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
PDF editoriale
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
716.16 kB
Formato
Adobe PDF
|
716.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1088261